Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
A phase 2 trial of Antineoplastons in Brain and spinal cord tumours, run by Burzynski Research Institute, completed.
Overview
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors is a phase 2 interventional study registered as NCT00003475 by Burzynski Research Institute, with 40 participants recorded, started 1996-02 and reaching its primary completion in 2011-05. Interventions recorded: Antineoplaston therapy (Atengenal + Astugenal). Conditions recorded: Malignant Brain Tumors.
Linked to the technology Antineoplastons because the registry's title names it ("antineoplastons") and Brain and spinal cord tumours among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialAntineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
Shares Antineoplastons (Burzynski clinic) and the tag pipeline.
- TrialStudy of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma
Shares Antineoplastons (Burzynski clinic) and the tag pipeline.
- TrialStudy of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
- TrialPost-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
- TrialStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
- TrialA Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS Tumors
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
- TrialA Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
- TrialA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Shares Brain and spinal cord tumours (all types) and the tag pipeline.